Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections
The WHO Department leads the global effort to end the epidemics of HIV, tuberculosis (TB), hepatitis, and sexually transmitted infections (STIs), ensuring that every person has equitable access to highest-quality people-centred scientific evidence and services, regardless of who they are or where they live.
About us

Programmatic innovations in TB prevention and care, in the context of the COVID-19 pandemic

Concept Introduction

The WHO Global Tuberculosis Programme is collecting case studies to document innovative approaches and lessons learnt to improve provision of TB services in times of COVID-19.  

The significant demand of the COVID-19 pandemic on health systems and economies, coupled with public health measures such as restricted movement, have exacerbated the pandemic’s adverse impact on TB services. As a chronic lung disease, TB may worsen outcomes in people with COVID-19. Successfully containing the double threat of TB and COVID-19, therefore requires innovation, impactful policies and global collaborations. 

WHO/GTB envisions to document (and publish on its website) case studies to enhance learning, innovation and evidence based decision making.

Guiding questions

  • To submit a country summary please complete the following questions.
  • You can use this template for new, ongoing or completed projects.
  • Please contact gtbprogramme@who.int if you have any questions.

 

1. Your information*

2. Thematic area*

Select

3. Background of the project*

4. Intervention & methodology*

5. Result*

6. Timeline of the project*

7. Additional information